What have you heard about
Research, development, and utilization of molecular therapies is on the rise.
The need for these new and innovative approaches has never been more critical.
There are over 7,000 unique rare diseases; 80% are genetic in origin.
%
of all cancer cases are rare cancers.
Over 350 cell and gene therapies are currently in development in the U.S.
The influx of these cutting-edge therapies is creating multiple knowledge gaps throughout healthcare.
Bring in the experts who know.
At TGCA understanding the complexities of molecular therapies is in our DNA.
Through the use of appropriate, unbiased, evidence-based tools and education we work with our clients to structure novel solutions that will ultimately change more lives for the better.
Regardless of where you fit in the care continuum, our experts can help.
Defining, Navigating, Advancing Genetic Medicine
TGCA is the only consulting firm specifically focused on helping clients develop knowledge, access data, and gain expertise to strategically navigate through the intricacies of molecular therapies.
Resources
TGCA: Defining, Navigating, Advancing Genetic Medicine
The need for new and innovative approaches to treat disease has never been more critical. The development and utilization of molecular therapies is revolutionizing healthcare. Cell therapy, gene...
The Random Genetic Event that Changed the World
Where did COVID-19 come from? Viruses infect every species on Earth: animals, plants and even bacteria. A virus can only infect a limited range of species. Typically these are related species, which...
SSRI Use is Associated with Reduced Opioid Use 30 Days After Total Knee Arthroplasty
There is a complicated two-way biological and psychological relationship between pain and depression. A poster from the University of Washington Medical Center presented at the 2019 American Pain...
Our Memberships
TGCA is a proud member of the following organizations:
We are here to help you.
Let’s Talk.